| Literature DB >> 26873942 |
Danilo Toni1, Svetlana Lorenzano2, Stefano Strano3.
Abstract
RATIONALE: Atrial fibrillation is associated with a high risk of stroke and its prevalence increases in subjects aged ≥65 years. After an ischemic stroke, the use of standard monitoring methods may underestimate the detection rate of atrial fibrillation. Hence, it is very likely that even patients having a first atherothrombotic or lacunar stroke with high burden of vascular risk factors are exposed to increased risk of developing atrial fibrillation in the subsequent years and atrial fibrillation may be the cause underlying possible recurrent strokes AIM AND HYPOTHESIS: The Silent Atrial Fibrillation aFter Ischemic StrOke (SAFFO) trial has the objective to evaluate the detection of atrial fibrillation or atrial flutter as first diagnosis by implantable loop recorder in patients with first-ever atherothrombotic or lacunar stroke. We hypothesize that the detection will be higher than that observed by using standard cardiac monitoring METHODS ANDEntities:
Keywords: Ischemic stroke; anticoagulants; antithrombotics; atrial fibrillation; implantable loop recorder; stroke subtype
Mesh:
Substances:
Year: 2016 PMID: 26873942 DOI: 10.1177/1747493016631356
Source DB: PubMed Journal: Int J Stroke ISSN: 1747-4930 Impact factor: 5.266